|
Press Releases |
|
 |
|
Friday, December 18, 2020 |
|
Hua Medicine Completes Registration Phase III Trials; Announces 52-Week Result for DAWN (HMM0302), Dorzagliatin's Phase III Combination with Metformin Trial |
Hua Medicine (the "Company", Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today announced: more info >> |
|
Wednesday, October 14, 2020 |
|
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin |
Hua Medicine (the "Company", Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder ("MAH") system, the Company has obtained the drug manufacturing permit for dorzagliatin, its investigational first-in-class drug, issued by the Shanghai Municipal Drug Administrative Bureau. more info >> |
|
Monday, August 17, 2020 |
|
Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China |
Bayer and Hua Medicine, a leading innovative drug development company, today announced a commercialization agreement and strategic partnership for dorzagliatin, a novel diabetes treatment, in China. more info >> |
|
Wednesday, July 1, 2020 |
|
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin |
Hua Medicine today announced the positive 24-week top-line results from HMM0302, a Phase III registration trial in China of its global first-in-class glucokinase activator dorzagliatin add-on to metformin, a first line oral antidiabetic therapy in Type 2 diabetes. more info >> |
|
Thursday, June 18, 2020 |
|
Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin Phase III Monotherapy Trial |
Hua Medicine (the "Company", Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today announced topline results from SEED (also known as HMM0301) more info >> |
|
Monday, April 27, 2020 |
|
Hua Medicine Announces Positive Results in the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor) |
Hua Medicine (the "Company", Stock Code: 2552. HK) today announces the positive results of the clinical study HMM0112. more info >> |
|
Monday, March 16, 2020 |
|
Hua Medicine Announces 2019 Annual Results |
Hua Medicine (the "Company", Stock Code on The Stock Exchange of Hong Kong Limited: 2552.HK), a global innovative drug research and development company focused on novel therapies for the treatment of diabetes, today announces the audited consolidated results of the Company and its subsidiaries for the year ended December 31, 2019. more info >> |
|
Friday, February 14, 2020 |
|
Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer |
Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, is pleased to announce that Dr. Fuxing Tang has joined Hua Medicine as Chief Technology Officer, VP of Formulation R&D and Product Development. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Fujitsu migrates service operations virtualization platform used by 3,000 companies to Nutanix and introduces migration support services utilizing proven expertise
Oct 10, 2025 23:25 JST
|
|
|
Shares of Golden Leaf International Group Limited Commence Trading on GEM of HKEX Today
Oct 10, 2025 19:10 HKT/SGT
|
|
|
TripGift(R) Unlocks Glocal Bucket List' Dreams With Launch of New Destination Gift Card SKUs and Marketplaces for Cities, Destinations and Experiences
Oct 10, 2025 15:00 HKT/SGT
|
|
|
IPO Temporarily Slows but Growth Trajectory Unchanged: How Did Hithium Reach Global No. 2 in Six Years?
Oct 10, 2025 14:18 HKT/SGT
|
|
|
Anime Tokyo Station: TV Anime 'SPYxFAMILY' Special Exhibition, New Designs Added for Admission Bonus Illustration Cards
Oct 10, 2025 11:30 JST
|
|
|
TANAKA to Provide Medals Expressing Every Runner's Trail through Flowing Curves for the Tokyo Legacy Half Marathon 2025
Oct 10, 2025 3:00 JST
|
|
|
Genequest and Fujitsu uncover new insights into genetics-lifestyle relationships through high-speed, reliable causal AI from Fujitsu Kozuchi
Oct 9, 2025 0:55 JST
|
|
|
Sharp Launches A3 MFPs (BP Series)
Oct 9, 2025 0:50 JST
|
|
|
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony in Shimonoseki for Large Car Ferry HAMANASU
Oct 9, 2025 0:42 JST
|
|
|
GSK Unveils Fast-Tracked IBP Transformation with OMP at Gartner Supply Chain Planning Summit
Oct 9, 2025 23:00 HKT/SGT
|
|
|
Honda Celebrates 30th Anniversary of CR-V
Oct 9, 2025 23:54 JST
|
|
|
DASSAI MOON Project, the World's First Test Brewing of Sake in Space
Oct 9, 2025 23:23 JST
|
|
|
Focus Graphite Announces Marketing and Investor Awareness Campaign
Oct 9, 2025 21:29 HKT/SGT
|
|
|
All-New Destinator Wins Gold Award at VMARK Vietnam Design Award 2025
Oct 9, 2025 22:17 JST
|
|
|
Laser Digital Partners with Solidus Labs to Advance Crypto-Native Market Surveillance
Oct 9, 2025 21:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|